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Reports in the scientiﬁc literature and in the
media have raised concerns that environmen-
tal chemicals, in particular those that persist
in the environment, may produce adverse
health effects in wildlife, domestic animals,
and humans by interfering with the endocrine
system (1–4). Some reported effects include
reproductive and developmental abnormali-
ties, increases in certain hormone-related can-
cers (breast, uterus, prostate, testis), and
declines in wildlife populations. Although the
issue of public health risks from exposure to
endocrine-disrupting chemicals (EDCs) con-
tinues to be rigorously debated, it is notewor-
thy that the British Royal Society recently
issued a report restating that the risks posed
by these chemicals remain of great concern
for people of many countries (5). Going a
step further than an earlier report from the
U.S. National Research Council (NRC) (6),
the British Royal Society report (5) acknowl-
edges that there is strong evidence to link
EDC exposure to effects in some organisms;
they further recommend that human expo-
sure be minimized, especially exposure of
pregnant women to EDCs such as plasticizers
and insecticides. The British Royal Society’s
response is a poignant reminder of the contin-
uing public health concerns about EDCs.
In 1998, the Endocrine Disrupter
Screening and Testing Advisory Committee
(EDSTAC) of the U.S. Environmental
Protection Agency (U.S. EPA) issued their
final report (7), which includes recommen-
dations of tests for estrogenic and antiestro-
genic environmental chemicals. The rodent
uterotropic response assay, long considered
the “gold standard” for determining estro-
genicity, was identiﬁed as a preferred in vivo
screen. Although much attention has been
focused on identifying protocol variables and
reproducibility between laboratories, direct
comparison of uterine responses between
rodent species has been rarely addressed. Rats
are commonly used in toxicologic testing,
and many studies have been performed in
this species (8–13). Because of our experience
with the CD-1 mouse and our previously
published data on the uterotropic responses
in this strain (14–18), we compared uterine
responses in this mouse strain with responses
in the Sprague-Dawley rat. We investigated
the sensitivity of both species to varying doses
of 17β -estradiol by comparing uterine wet
weight increase and a number of morpho-
logic and biochemical end points that are
known estrogenic responses in both species
(19–24). Because developing tissues are par-
ticularly susceptible to perturbation by hor-
mones (25,26), we restricted our study to the
use of immature rather than adult ovariec-
tomized animals. Our study shows the sensi-
tivity of the mouse compared to the rat to
estradiol stimulation and suggests that the
mouse is a suitable model for testing EDCs
for estrogenic activity. 
Materials and Methods
Immature mouse uterotropic bioassay. Timed-
pregnant CD-1 mice [Crl:CD-1(ICR)],
obtained from the breeding colony at the
National Institute of Environmental Health
Sciences (NIEHS), delivered their young on
day 19 of gestation. At birth (day 1), all pups
were sorted by sex and redistributed so that
all litters were standardized to 10 female
pups per dam. Male pups were used in
another study. All animals were housed
under controlled lighting (12 hr light:12 hr
dark) and temperature (21–22°C) condi-
tions. Mice were given fresh reverse-osmo-
sis/deionized (RO/DI) water and NIH-31
rodent diet (an open formula, autoclavable,
natural-ingredient rodent diet; Zeigler
Brothers, Inc., Gardners, PA) ad libitum. All
animal procedures complied with National
Institutes of Health (NIH)/NIEHS animal
care guidelines. Female pups were weaned
on day 17 and housed five mice per cage.
Starting on the day of weaning, immature
mice (n = 5/treatment group) were subcuta-
neously injected with varying doses of
17β -estradiol (0, 0.1, 1, 10, 100, or 500
µg/kg/day; Sigma Chemical Company, St.
Louis, MO) dissolved in corn oil. Mice were
injected for 3 consecutive days and killed by
cervical dislocation on the morning of the
fourth day (20 days of age), and body
weights were determined. After making an
incision in the skin and the abdominal mus-
cle, the uterine cervix was cut away from the
vagina fornix. Because ﬂuid imbibition is an
estrogen response, care was taken to retain
all uterine luminal fluid. The uterus was
then removed by gently lifting tissue anteri-
orly and trimming away the mesometrium.
A cut was made at the uterotubal junction,
thus preserving the integrity of both uterine
horns and avoiding loss of uterine ﬂuid. The
uterus was immediately weighed, placed on
absorbent cardboard in order to maintain the
original in vivo orientation, fixed in cold
Bouin’s ﬁxative, and processed for histologic
and morphometric examination. We then
calculated the uterine wet weight:body
weight ratios. Collection techniques and sim-
ilar uterotropic responses and measurements
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The traditional rodent uterotropic response assay has been incorporated into the U.S.
Environmental Protection Agency’s screening and testing program for environmental endocrine-dis-
rupting chemicals (EDCs). While much effort continues to focus on determining protocol variables,
few studies compare uterotropic responses in rats, a species commonly used in toxicologic testing,
with other rodent species. In this study, we compared uterine responses in immature outbred CD-1
mice and Sprague-Dawley rats. After three daily subcutaneous injections with 17β -estradiol
(0.1–500 µg/kg/day), immature mice and rats demonstrated a similar dose–response increase in
absolute uterine wet weight and uterine weight:body weight ratio. Further, morphologic and bio-
chemical parameters of estrogenicity, including uterine epithelial cell height and number, gland
number, and induction of estrogen-responsive proteins lactoferrin and complement C3, mirror wet
weight increases. We conclude that mice are as well suited as rats for the uterotropic bioassay.
Because of the advantages of using mice, including lower costs, less space required, and smaller
amounts of compound needed for tests, mice should be given appropriate consideration in testing
paradigms for EDCs. Key words: complement C3, dose–response modeling, endocrine disruptors,
endocrine modulators, environmental estrogens, estrogens, lactoferrin, risk assessment extrapola-
tions, uterotropic bioassay. Environ Health Perspect 109:821–826 (2001). [Online 1 3 August 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/109p821-826banks/abstract.htmlin other groups of mice have been previously
reported by this laboratory (16,17). 
Immature rat uterotropic bioassay.
Timed-pregnant rats [Tac:N(SD)fBR] were
obtained from Taconic Laboratories (Raleigh,
NC) on gestation day 15. At birth (day 1), all
pups were sorted by sex and redistributed so
that all litters were standardized to eight
female pups per dam. All animals were
housed in a temperature-controlled room
(21–22°C) with a 12 hr light:12 hr dark
cycle. Rats were provided fresh RO/DI water
and NIH-31 lab chow ad libitum. All animal
procedures complied with NIH/NIEHS ani-
mal care guidelines. Rats were weaned on day
23 and housed four per cage. Starting on the
day of weaning, rats (n = 4/treatment group)
were subcutaneously injected with varying
doses of 17β -estradiol (0, 1, 10, 100, or 500
µg/kg/day) dissolved in corn oil for 3 consec-
utive days; lower doses were not tested in rats
because reports in the literature showed no
significant difference between lower doses
and control values in uterine wet weight
changes (11). Rats were euthanized by cervi-
cal dislocation on the day after the last injec-
tion (day 26). Body weights and uterine wet
weights were determined as described for the
mice. Uterine tissues were fixed in Bouin’s
ﬁxative and processed for histologic and mor-
phometric examination.
Uterine wet weight determination.
Uterine wet weight:body weight ratios were
calculated for each animal by dividing the
uterine wet weight by the body weight and
multiplying by 100. We used StatView SE +
Graphics (ABACUS Concepts, Inc., Berkeley,
CA) to determine the mean and SE and to
perform analysis of variance (ANOVA) using
the Fisher’s test of signiﬁcance (p < 0.05).
Uterine histologic observations. Uterine
tissues were processed and embedded in
parafﬁn with one horn placed longitudinally
and the other placed cross-wise; sections
were cut at 4 µm and stained with hema-
toxylin and eosin (H&E). We quantitated
histologic responses using an Olympus BH-
2 Microscope (Olympus Corp., New Hyde
Park, NY) interfaced with an image analysis
system (Southern Micro Instruments,
Atlanta, GA) as described previously (22,27). 
Cell height determinations. To determine
cell height, we obtained three measurements
from each of three areas from a minimum of
three animals (at least 27 measurements per
group). We measured cell height in longitudi-
nally embedded tissues, always from the mid-
dle of the uterus and away from the oviduct or
cervical segments. We calculated the mean for
each area and then the mean for each animal.
We then used these animal means to deter-
mine the mean ± SE for each treatment group. 
Cell number determination. We deter-
mined the number of uterine epithelial cells
per micrometer of basement membrane by
obtaining three counts per area (in longitu-
dinally embedded tissues, as described
above) from three areas per animal from a
minimum of three animals (at least 27 mea-
surements per treatment group). We
counted the epithelial cells in a length of
approximately 100 µm uterine epithelium
and calculated the number of cells per
micrometer of basement membrane. We cal-
culated the mean for each area and then the
mean for each animal. We used these animal
means to determine the mean ± SE for each
treatment group. 
Gland number determinations. We
counted the number of glands in cross-sec-
tions of uterine tissues obtained from the
middle region of the uterus. We counted
glands in three sections per animal from a
minimum of four animals per treatment
group (a minimum of 12 counts per group).
The counts for each animal were averaged,
and these means were used to determine the
mean ± SE for each group. 
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Figure 1. Uterine weight:body weight ratio of mice (n = 5) and rats (n = 4) that
received varying subcutaneous doses of 17β -estradiol once daily for 3 days.
See “Materials and Methods” for details. Values shown are the mean ± SE.
The shaded areas represent control values (mean ± SE). The slope is similar
for both mice and rats, but the sensitivity of mice is higher than that of rats at
all doses tested.
Figure 2. Epithelial cell height in the uterotropic bioassay of immature mice and
rats. Values represent the mean ± SE of three measurements from three areas
from three animals (total of 27 counts/group). For doses ≥ 1 µg/kg/day in both mice
and rats, there was a signiﬁcant increase over the corresponding control values. 
*Statistically signiﬁcant differences between treated mice and rats and their respective
controls (p < 0.05).
Table 1. Comparison of the immature mouse and rat in the uterotropic bioassay.
Uterine wet weight (g) Uterine weight:body weight ratio
17β -Estradiol Fold induction Fold induction
(µg/kg/day) Body weight (g)  Actual over control Relative over control
Mouse
0  9.58 ± 0.374 0.011 ± 0.001 1.00 0.111 ± 0.006 1.00
0.1  9.28 ± 0.428 0.012 ± 0.001 1.09 0.131 ± 0.012 1.18
1 10.38 ± 0.504 0.025 ± 0.002* 2.27 0.242 ± 0.009 2.18
10 9.63 ± 0.809 0.044 ± 0.006* 4.00 0.450 ± 0.046 4.06
100 10.58 ± 0.301 0.062 ± 0.008* 5.64 0.578 ± 0.059 5.21
500 11.01 ± 0.221* 0.073 ± 0.007* 6.64 0.725 ± 0.068 6.54
Rat
0 77.31 ± 1.87 0.047 ± 0.004 1.00 0.061 ± 0.006 1.00
0.1 ND ND ND ND ND
1 70.50 ± 3.48 0.085 ± 0.003* 1.81 0.121 ± 0.010 1.98
10 55.47 ± 2.02* 0.108 ± 0.008* 2.30 0.208 ± 0.014 3.41
100 55.57 ± 2.17* 0.150 ± 0.007* 3.19 0.283 ± 0.010 4.64
500 67.27 ± 0.56* 0.217 ± 0.017* 4.62 0.344 ± 0.028 5.64
ND, not determined. Numbers represent mean ± SE.
*Statistically signiﬁcant at p < 0.05.
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*Uterine biochemical observations.
Lactoferrin (LF) and complement C3 have
been shown to be estrogen-responsive pro-
teins in the mouse and rat uterus (18). After
exposure to estrogen, both proteins were
induced in uterine epithelial cells, and LF
was shown to increase with increasing doses
of estrogen (28). Thus, we examined these
two proteins to determine the sensitivity of
each species to increasing estrogenic doses
and to determine the expression of these two
estrogen-inducible proteins.
LF immunocytochemistry. Mouse and
rat uterine tissue sections were immunos-
tained for the presence of LF using horserad-
ish peroxidase immunocytochemistry as
previously described (28). Briefly, sections
were incubated with rabbit anti-mouse LF
(28) for 2 hr at room temperature, or with
normal rabbit IgG (Accurate Chemical Co.,
Westbury, NY) diluted 1:200 or without LF
antibody for negative controls. We used the
image analysis system (Southern Micro
Instruments) to score LF intensity. We mea-
sured staining intensity in a minimum of three
areas (three measurements per area) for each of
three animals. The intensity scale ranged from
0 (no stain) to 50 (very intense stain).
Complement C3 immunocytochemistry.
Mouse and rat uterine tissue sections were
immunostained for complement C3. Tissue
sections were incubated with goat anti-mouse
complement C3 (primary antibody) diluted
1:5,000 (Cappel, Durham, NC) for 2 hr at
room temperature. We used negative con-
trols as described for LF immunolocalization.
The immunostain was detected using an
avidin:biotinylated enzyme complex (ABC)
method. Briefly, tissue sections were rinsed
with Tris-buffered saline containing 0.6%
Tween-20 (TBS-T), incubated with biotiny-
lated anti-goat antibody diluted 1:500 for 30
min at room temperature, rinsed with TBS-
T, then incubated with ABC-AP (ABC-AP
kit; Vector Laboratories, Burlingame, CA)
for 30 min at room temperature. Tissue sec-
tions were washed with TBS-T and rinsed
brieﬂy with TBS (pH 9.5) before the alkaline
phosphatase (AP) substrate was applied. We
prepared the color enhancement according to
directions in the AP substrate kit IV (blue;
Vector Laboratories) and incubated the tissue
sections for approximately 10 min. Tissues
were rinsed in distilled water, dehydrated,
and coverslipped. We determined the inten-
sity of C3 intensity as described for LF.
Statistical analysis. We performed statis-
tical analysis by ANOVA (StatView SE +
Graphics); values were determined to be sig-
niﬁcant at p < 0.05.
Results
Uterotropic wet weight. The results of the
uterotropic bioassays in mice and rats are
shown in Table 1. Although there are differ-
ences in body weight in mice and rats after
estradiol treatment, none of the animals
appeared ill; thus, differences in body weight
most likely did not have any confounding
effect on this study. We observed a similar
dose–response increase in uterine wet weight
in both species with increasing doses of 17β -
estradiol. We expressed data as the uterine
weight to body weight ratio (Table 1, Figure
1). Doses ranging from 1 to 500 µg/kg/day
were statistically significant for both mice
and rats compared to their corresponding
controls.
Uterine histologic observations. Epithelial
cell height. Figure 2 shows the epithelial cell
height results for the immature mouse and
rat. The increase in cell height was higher in
immature rats treated with ≥ 1 µg/kg/day
17β -estradiol than in their corresponding
controls. Uterine epithelial cell height in the
mouse followed the same pattern of increase
as in the rat, but the rat demonstrated a
greater increase over controls with this end
point than the mouse at given doses. In
Figure 3, photomicrographs show the effects
of 17β -estradiol treatment (500 µg/kg/day)
on epithelial cell height in mice (Figure 3B)
and rats (Figure 3D). 
Epithelial cell number. Figure 4 shows
an increase in cell number in response to
≥ 10 µg/kg/day 17β -estradiol in both mice
and rats. There was a greater increase over
controls in mice than in rats at all doses. The
increase in cell number is also shown in
Figure 3.
Uterine gland number. The number of
glands is increased in mice in response to ≥ 1
µg/kg/day 17β -estradiol (Figure 5). However,
there is no apparent increase in gland number
in rats after any dose of estradiol used in this
study. Thus, there is a striking difference
between these two species in the ability of
17β -estradiol to elicit gland formation in
rodents of this age. 
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Figure 3. Photomicrograph of uterine tissues from immature mice (A,B) and rats (C,D). (A) The unstimulated
uterus from an immature mouse shows a single layer of cuboidal or low columnar cells lining the uterine
lumen; there is minimal differentiation in the stroma. (B) The stimulated uterus from an immature mouse
treated with 17β -estradiol (500 µg/kg/day) for 3 days shows tall columnar epithelial cells; the stromal cells
have round nuclei and more space between nuclei. (C) The unstimulated uterus from an immature rat
shows low cuboidal epithelium lining the uterine lumen, and stromal cells are undifferentiated and unre-
sponsive as in the immature mouse. (D) The stimulated uterus from an immature rat treated with 17β -estra-
diol (500 µg/kg/day) for 3 days shows tall pseudostratified columnar cells and differentiated responsive
stromal cells. Magniﬁcation, 200× for all photomicrographs.
Figure 4. Epithelial cell number in the uterotropic
bioassay of immature mice and rats. Values rep-
resent the number (mean ± SE) of epithelial cells
per micrometer of basement membrane for three
counts from three areas from three animals for
each dose (total of 27 counts per group). 
*Statistically significant differences between mice and
rats and their respective controls (p < 0.05).
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*Uterine LF and C3 immunohistochem-
istry. The results of LF quantitation are
shown in Figure 6. We detected LF in all of
the 17β -estradiol–treated groups of imma-
ture mice and rats. We previously reported a
dose-dependent increase in LF immunohisto-
chemistry over a tighter dose–response curve
than is shown in Figure 6 (28). For all of the
doses tested, the highest measurements were
seen in mice. Figure 7 shows the pattern of
LF immunostaining for both mice and rats.
The cellular distribution of LF in the stimu-
lated mouse uterus (Figure 7B) is different
from that in the stimulated rat uterus (Figure
7D): LF is evenly distributed over the entire
uterine epithelial cell in the mouse (Figure
7B), whereas LF in the rat is more apical
(Figure 7D). Negative control slides showed
no staining. 
Tissue sections immunostained for com-
plement C3, another estrogen-inducible pro-
tein, are shown in Figure 8. Although
17β -estradiol induced C3 in the same cell
type, uterine epithelial cells, the cellular distri-
bution was different in mice and rats. C3 was
expressed in the apical portion of luminal
epithelial cells of the 17β -estradiol–treated
mouse (Figure 8B), whereas C3 was more
evenly distributed throughout the uterine
epithelial cells of the 17β -estradiol–treated
rat. Image analysis results of the C3
immunostained tissue sections were similar to
those of LF-immunostained  tissue (data not
shown). Thus, both the mouse and the rat
show a strong staining reaction for both LF
and C3 in uterine epithelial cells in response
to 17β -estradiol, but the pattern of staining
varied between the two species. The differen-
tial distribution of these two proteins in mice
and rats has been discussed in more detail in a
recent report from our laboratory (24). 
Discussion
The data presented in this paper shows the
sensitivity and degree of uterine response of
the CD-1 mouse and the Sprague-Dawley rat
to 17β -estradiol in the in vivo uterotropic
bioassay. Of particular interest is the differ-
ence in some end points between the strains,
whereas other end points are similar. Some of
these differences have been noted in the past
and go back at least 40 years (29). However,
with renewed interest in using the rodent
uterotropic bioassay as a screen for endocrine-
disrupting substances, a more direct compari-
son is of interest to laboratories desiring to use
an in vivo assay to determine the estrogenicity
of compounds. Therefore, we conducted the
present study to compare the estrogenic
responses in mice and rats and to provide
additional morphologic and biochemical end
points that may be useful for increasing the
information that can be obtained from the
uterotropic bioassay. For the purposes of this
study, we compared the responses of rats and
mice in the linear portion of the uterotropic
dose–response curve; higher doses show an S-
shaped response for uterine wet weight (16),
as well as other estrogen-responsive end
points (30).
LF and C3 are strongly expressed in
uterine luminal epithelial cells of both rats
and mice after 17β -estradiol treatment. It is
interesting to note the specific pattern of
expression of these two proteins and the cel-
lular distribution of each protein within the
epithelial cells of rats and mice. In the
mouse, LF is distributed throughout the
cytoplasm of the uterine epithelial cells, and
C3 localizes primarily at the apical tip. In
the rat, LF localizes at the apical tip, and C3
is distributed throughout the cytoplasm.
This pattern of protein distribution agrees
with an earlier report (24). The differential
cellular distribution of both proteins in rats
Articles • Banks et al.
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Figure 5. Number of uterine glands in the
uterotropic bioassay of immature mice and rats.
Values shown are the number of glands per sec-
tion (mean ± SE) for three sections from three ani-
mals for each dose (total of 27 counts per group). 
*Statistically signiﬁcant differences between each mice
and rats and their respective controls; there is a marked
response in mice with this end point, whereas few uter-
ine glands are present in the rat regardless of the 17β -
estradiol dose (p < 0.05).
Figure 6. Quantitation of image analysis of LF
immunostaining in immature mice and rats. Values
represent the intensity of staining (mean ± SE)
determined from measuring three readings from
three areas from three animals (total of 27 counts
per group). LF showed a consistently stronger
response in mouse tissues than in rat tissues.
Quantitation of C3 showed an identical response
(data not shown).
*Statistically significant differences between rats and
mice and their respective controls (p < 0.05). 
Figure 7. Immunohistochemical localization of LF in the uterotropic bioassay of immature mice and rats.
(A) The unstimulated uterus from an immature mouse shows no apparent LF staining. (B) The stimulated
uterus from an immature mouse treated 3 days with 500 µg/kg/day 17β -estradiol shows intense immuno-
staining in uterine epithelial cells; note the localization of LF throughout the cytoplasm. (C) The unstimu-
lated uterus from an immature rat shows no apparent LF staining. (D) The stimulated uterus from an
immature rat treated 3 days with 500 µg/kg/day 17β -estradiol shows specific LF staining in the luminal
epithelial cells; there are fewer intensely stained cells than in the stimulated mouse, and the immunostain-
ing is primarily at the apical surface of the epithelial cells. Negative controls, as described in “Materials
and Methods,” demonstrated no immunostaining. Magniﬁcation, 200× for all photomicrographs. 
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*and mice may be because of different pat-
terns of gene expression within each species.
Although most end points showed simi-
larities between mice and rats, there was an
increase in uterine gland formation after
estrogen treatment in the mouse but not in
the rat. Previous studies have shown that
during postnatal development, uterine gland
differentiation is sensitive to estrogen pertur-
bation, resulting in inhibition of gland dif-
ferentiation in both rats (31) and mice (32).
However, after postnatal differentiation, the
response of uterine glands to estrogen in the
immature animal is quite different in rats
and mice. Similar to humans, mouse uterine
glandular epithelium responds to estrogen by
becoming more convoluted and by increas-
ing secretions.
Values for control and 17β -estradiol–
treated rat tissues reported in this study are
consistent with those from other laboratories
(33). Furthermore, uterotropic responses in
immature Alpk:AP rats (8) is similar to
responses observed in Sprague-Dawley rats
in this study. In the Alpk:AP rats (8), the
uterine wet weight (mean ± SE) was 38.2 ±
7.3 mg in controls and 95.4 ± 17.0 mg in
rats treated with 10 µg/kg/day 17β -estradiol.
In the Sprague-Dawley rats in the present
study, the uterine wet weight (mean ± SE)
was 47 ± 4 mg in controls and 108 ± 8 mg
in rats treated with 10 µg/kg/day 17β -estra-
diol. This suggests similar estrogenic
responses in two different strains of rats. Our
data are also consistent with control values
reported in other studies using immature
rats (8,10,12). Further comparison after
estrogen treatment is not possible because
these studies only reported “blotted” uterine
weight instead of actual uterine wet weight,
which includes uterine luminal fluid. We
specifically included uterine luminal con-
tents because fluid imbibition is an impor-
tant early estrogenic response. 
Although we did not compare different
routes of exposure between mice and rats in
our study, a previous report showed a similar
magnitude of uterine response in rats
between oral gavage and subcutaneous injec-
tion (10). Although we used a small number
of rats in this study, the data are consistent
with other studies in the literature; this leads
us to believe that our data are representative
of responses seen in rat uterotropic bioassays. 
The present study was designed to com-
pare species differences in uterine response
between immature mice and rats. We did not
compare immature and adult ovariectomized
animals because earlier studies demonstrated
that immature animals are more sensitive to
stimulation with estrogens than adult
ovariectomized animals (34). Kang et al. (35)
has recently reconﬁrmed this. Thus, the age
of the animals must be considered in design-
ing the most sensitive screening methods for
estrogenic chemicals.
As reported by other laboratories (13,36),
there was a greater variation in body weights
in all of the treatment groups in rats com-
pared to mice. Also, rats showed a general
decrease in body weight after 17β -estradiol
treatment, and mice showed an increase with
similar treatment. This greater variation in
body weight in the rat can decrease the signif-
icance of the results and thus make the estro-
genic effect of test chemicals less apparent, so
that weak estrogens may not be detected.
Therefore, decreased variability afforded by
the mouse may result in decreased numbers of
animals needed for testing. The potentially
smaller numbers of animals and the certainty
of lower animal husbandry costs and smaller
amounts of compound needed for tests (due
to the smaller body size of mice) support the
use of mice in this screen until substitute in
vitro models can be validated.
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